Huntington's disease and HDACi: would sulpiride and valproate be of therapeutic value?

Tremolizzo, L; Rodriguez-Menendez, V; DiFrancesco, J C; Sala, G; Galbussera, A; Appollonio, I; Ferrarese, C

Tremolizzo, L; Rodriguez-Menendez, V; DiFrancesco, J C; Sala, G; Galbussera, A; Appollonio, I; Ferrarese, C.

Med Hypotheses ; 69(4): 964-5, 2007.

Article in En | MEDLINE | ID: mdl-17428619

Subject(s)

Histone Deacetylases/metabolism; Huntington Disease/drug therapy; Huntington Disease/physiopathology; Sulpiride/therapeutic use; Valproic Acid/therapeutic use; Anticonvulsants/therapeutic use; Antipsychotic Agents/therapeutic use; Histone Deacetylases/drug effects; Humans; Huntington Disease/enzymology; Motor Activity/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sulpiride / Valproic Acid / Huntington Disease / Histone Deacetylases Limits: Humans Language: En Journal: Med Hypotheses Year: 2007 Type: Article

Search on Google

XML

PubMed Links